STOCK TITAN
  1. Home
  2. MTACW

MedTech Acquisition Corporation Stock Price, News & Analysis

MTACW

Company Description

MedTech Acquisition Corporation (Nasdaq: MTACW) is a publicly traded company.

MTACW stock has gained 336.0% over the past year.

This page provides a comprehensive overview of MTACW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+336%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

MedTech Acquisition Corporation (MTACW) stock. Over the past 12 months, the stock has gained 336.0%.

Latest News

View All
+50.63%

MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders

acquisition
-2.20%

MedTech Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

acquisition
—

MedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing February 8, 2021

acquisition
—

MedTech Acquisition Corporation Announces Closing of Upsized $250,000,000 Initial Public Offering

IPO offering acquisition
—

MedTech Acquisition Corporation Announces Pricing of Upsized $220,000,000 Initial Public Offering

IPO offering acquisition

MedTech Acquisition Corporation has 5 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all MTACW news →

SEC Filings

View All

No SEC filings available for MTACW.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months